BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34996827)

  • 1. Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression.
    Ji F; Zhang J; Liu N; Gu Y; Zhang Y; Huang P; Zhang N; Lin S; Pan R; Meng Z; Feng XH; Roessler S; Zheng X; Ji J
    Gut; 2022 Nov; 71(11):2313-2324. PubMed ID: 34996827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome.
    Li D; Yu T; Hu J; Wu J; Feng S; Xu Q; Zhu H; Zhang X; Zhang Y; Zhou B; Gu L; Zeng Z
    Oxid Med Cell Longev; 2021; 2021():5175581. PubMed ID: 35003516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From hepatofibrosis to hepatocarcinogenesis: Higher cytochrome P450 2E1 activity is a potential risk factor.
    Gao J; Wang Z; Wang GJ; Gao N; Li J; Zhang YF; Zhou J; Zhang HX; Wen Q; Jin H; Qiao HL
    Mol Carcinog; 2018 Oct; 57(10):1371-1382. PubMed ID: 29917271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
    Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
    Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis.
    Niu Y; Wu Z; Shen Q; Song J; Luo Q; You H; Shi G; Qin W
    Dig Liver Dis; 2013 Dec; 45(12):1041-8. PubMed ID: 23891548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAS40 hyperexpression promotes hepatocarcinogenesis.
    Qi Z; Zhang T; Song L; Fu H; Luo H; Wu J; Zhao S; Zhang T; Guo L; Jin L; Zhang H; Huang G; Ma T; Wu Y; Huang L
    EBioMedicine; 2020 Jan; 51():102604. PubMed ID: 31901857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.
    Wang F; Huang J; Zhu Z; Ma X; Cao L; Zhang Y; Chen W; Dong Y
    Cancer Prev Res (Phila); 2016 Sep; 9(9):739-49. PubMed ID: 27339169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma.
    Eun HS; Cho SY; Lee BS; Seong IO; Kim KH
    Mol Med Rep; 2018 Dec; 18(6):4865-4876. PubMed ID: 30280198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.
    Komoll RM; Hu Q; Olarewaju O; von Döhlen L; Yuan Q; Xie Y; Tsay HC; Daon J; Qin R; Manns MP; Sharma AD; Goga A; Ott M; Balakrishnan A
    J Hepatol; 2021 Jan; 74(1):122-134. PubMed ID: 32738449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
    Wang P; Song X; Cao D; Cui K; Wang J; Utpatel K; Shang R; Wang H; Che L; Evert M; Zhao K; Calvisi DF; Chen X
    Cell Death Dis; 2020 Feb; 11(2):91. PubMed ID: 32019910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
    Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
    J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy.
    Wang X; Liao X; Yang C; Huang K; Yu T; Yu L; Han C; Zhu G; Zeng X; Liu Z; Zhou X; Qin W; Su H; Ye X; Peng T
    Oncol Rep; 2019 Mar; 41(3):1586-1602. PubMed ID: 30628708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
    Arfianti A; Pok S; Barn V; Haigh WG; Yeh MM; Ioannou GN; Teoh NC; Farrell GC
    J Hepatol; 2020 Jul; 73(1):140-148. PubMed ID: 32302728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
    Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
    Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.